Acute Inflammation in Cerebrovascular Disease: A Critical Reappraisal with Focus on Human Studies

• Tipo: Artigo em Revista Científica Internacional
• Data: 2021

Autores

Dias, RA (Autor) Outra; Dias, L (Autor) Outra; Elsa Azevedo (Autor) FMUP; Castro, P (Autor) Outra

Revista

Título: Life

Vol. 12

Página Final: 1103

ISSN: 0024-3019

Editora: MDPI

Indexação

ISI Web of Knowledge - 5 Citações

Scopus - 5 Citações

Outras Informações

ID Authenticus: P-00V-KK6

DOI: 10.3390/life11101103

Abstract (EN): Recent attention has been focused on the field of inflammatory biomarkers associated with vascular disorders, regarding diagnosis, prognosis, and possible therapeutical targets. In this study, we aimed to perform a comprehensive review of the literature regarding the use of inflammatory biomarkers in stroke patients. We searched studies that evaluated inflammation biomarkers associated with Cerebrovascular Disease (CVD), namely, ischemic Stroke (IS), Intracerebral Hemorrhage (ICH) and Cerebral Venous Thrombosis (CVT). As of today, neutrophil-lymphocyte ratio (NLR) seems the be the most widely studied and accepted biomarker for cerebrovascular disease due to its easy access and availability. Although demonstrated as a prognostic risk factor, in IS, ICH and CVT, its diagnostic role is still under investigation. Several other prognostic factors could be used or even combined together into a diagnostic or prognostic index. Multiple inflammatory biomarkers appear to be involved in IS, ICH, and CVT. Blood inflammatory cells, easily measured and accessible at admission may provide information regarding accurate diagnosis and prognosis. Although not yet a reality, increasing evidence exists to suggest that these may become potential therapeutic targets, likely influencing or mitigating complications of CVD and improving prognosis. Nevertheless, further larger, well-designed randomized clinical trials are still needed to follow up this hypothesis.</p>

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 20